Boston Scientific (NYSE:BSX) Upgraded to “Strong-Buy” at Leerink Partnrs
Leerink Partnrs upgraded shares of Boston Scientific (NYSE:BSX – Free Report) to a strong-buy rating in a report issued on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Boston Scientific’s Q2 2025 earnings at $0.73 EPS, Q3 2025 earnings at $0.72 EPS, Q4 2025 earnings at $0.73 EPS, FY2025 earnings at $2.93 EPS, Q1 […]
Leerink Partnrs upgraded shares of Boston Scientific (NYSE:BSX – Free Report) to a strong-buy rating in a report issued on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Boston Scientific’s Q2 2025 earnings at $0.73 EPS, Q3 2025 earnings at $0.72 EPS, Q4 2025 earnings at $0.73 EPS, FY2025 earnings at $2.93 EPS, Q1 […]
